Please assess the completion status of the following clinical trial:

Trial Title: Alternative Antibiotic Regime in the Treatment of GAgP

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The periodontal diagnosis of subjects with GAgP was established on the basis of clinical and radiographic criteria defined by the 1999 International World Workshop for a Classification of Periodontal Diseases and Conditions.~* Patients were included if they were between 18 and 35 years of age and otherwise healthy.~Exclusion Criteria:~* if the patients had any known systemic diseases or conditions that can/could influence the periodontal status (cancer, cardiovascular and respiratory diseases)~* history of hepatitis or HIV infection,~* immunosuppressive chemotherapy~* current pregnancy, planning a pregnancy or lactation~* requirement for antibiotic prophylaxis~* oral diseases other than GAgP, ongoing orthodontic therapy~* a history of antibiotic therapy or periodontal treatment within the preceding six months.~* Subjects were excluded if they had known allergies to quinolones or penicillin or metronidazole~* Not willing to participate to the study.~* Not accept to sign written informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- amoxicillin+metronidazole (Type: ACTIVE_COMPARATOR): amoxicillin+metronidazole group received a combination of 500 mg of amoxicillin and 500 mg metronidazole three times per day for 7 days.
- moxifloxacin (Type: EXPERIMENTAL): The moxifloxacin group received 400 mg moxifloxacin, once in a day for 7 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).